B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition

We identified the PIKFYVE inhibitor apilimod as a potent and selective cytotoxic agent against B-cell non-Hodgkin lymphoma (B-NHL). Our data robustly establish PIKFYVE as the target through which apilimod kills B-NHL cells and show that apilimod-induced death in B-NHL is mediated by broad disruption...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Autophagy
Main Authors: Gayle, Sophia, Landrette, Sean, Beeharry, Neil, Conrad, Chris, Hernandez, Marylens, Beckett, Paul, Ferguson, Shawn M., Xu, Tian, Rothberg, Jonathan, Lichenstein, Henri
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Autophagic Punctum
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486370/
https://ncbi.nlm.nih.gov/pubmed/28350209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15548627.2017.1304871
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados